Nanjing Pharmaceutical and Others Established Equity Investment Fund Company with a Registered Capital of 750 million.

According to the Tianyancha App, recently, Nanjing Medicine Group Qianglian No.1 Equity Investment Fund Co., Ltd. was established, with Peng Yuping as the legal representative. The registered capital is 750 million RMB, and the business scope includes equity investment, private equity fund activities such as equity investment, investment management, asset management, enterprise management consulting. It is jointly held by Nanjing Medicine, Nanjing New Industry Health Qianglian Mergers and Acquisitions Equity Investment Fund Partnership Enterprise, and Nanjing New Industry Emerging Industry Investment Management Co., Ltd.